CTLA4-Ig abrogates the anti-globulin response and prolongs cardiac allograft survival after anti-CD2 treatment

Beyers, 1989, Activation of T lymphocytes via monoclonal antibodies against rat cell surface antigens with particular reference to CD2 antigen, Immunol Rev, 111, 59, 10.1111/j.1600-065X.1989.tb00542.x Brown, 1989, The CD2 antigen associates with the T-cell antigen receptor CD3 antigen complex on the surface of human T lymphocytes, Nature, 339, 551, 10.1038/339551a0 Meuer, 1984, An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein, Cell, 36, 897, 10.1016/0092-8674(84)90039-4 Bierer, 1988, Interaction of CD2 with its ligand, LFA-3, in human T cell proliferation, J Immunol, 140, 3358, 10.4049/jimmunol.140.10.3358 Moingeon, 1989, The structural biology of CD2, Immunol Rev, 111, 111, 10.1111/j.1600-065X.1989.tb00544.x Sehajpal, 1993, Synergism between the CD3 antigen- and CD2 antigen-derived signals. Exploration at the level of induction of DNA-binding proteins and characterization of the inhibitory activity of cyclosporine, Transplantation, 55, 1118, 10.1097/00007890-199305000-00035 van der Merwe, 1994, Human cell-adhesion molecule CD2 binds CD58 [LFA-3] with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59, Biochemistry, 33, 10149, 10.1021/bi00199a043 Nakamura, 1990, Relative contribution of CD2 and LFA-1 to murine T and natural killer cell functions, J Immunol, 145, 3628, 10.4049/jimmunol.145.11.3628 Davis, 1996, The structure and ligand interactions of CD2: implications for T-cell function, Immunol Today, 17, 177, 10.1016/0167-5699(96)80617-7 Ohno, 1991, Induction of negative signal through CD2 during antigen-specific T cell activation, J Immunol, 147, 2100, 10.4049/jimmunol.147.7.2100 Miller, 1993, Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses, J Exp Med, 178, 211, 10.1084/jem.178.1.211 Mentz, 1995, Involvement of cAMP in CD3 T cell receptor complex- and CD2-mediated apoptosis of human thymocytes, Eur J Immunol, 25, 1798, 10.1002/eji.1830250648 Rouleau, 1997, CD2 induced apoptosis of peripheral T cells, Transplant Proc, 29, 2377, 10.1016/S0041-1345(97)00410-7 Mollereau, 1996, CD2-induced apoptosis in activated human peripheral T cells: a Fas-independent pathway that requires early protein tyrosine phosphorylation, J Immunol, 156, 3184, 10.4049/jimmunol.156.9.3184 Dumont, 1998, Potent apoptotic signaling and subsequent unresponsiveness induced by a single CD2 mAb [BTI-322] in activated human peripheral T cells, J Immunol, 160, 3797 Bonnefoy-Berard, 1998, In vitro functional properties of antithymocyte globulins: clues for new therapeutic applications?, Transplant Proc, 30, 4015, 10.1016/S0041-1345(98)01323-2 Ida, 1998, Activation-induced NK cell death triggered by CD2 stimulation, Eur J Immunol, 28, 1292, 10.1002/(SICI)1521-4141(199804)28:04<1292::AID-IMMU1292>3.0.CO;2-A Bromberg, 1991, Anti-CD2 monoclonal antibodies alter cell-mediated immunity in vivo, Transplantation, 51, 219, 10.1097/00007890-199101000-00036 Chavin, 1993, Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects, Transplantation, 55, 901, 10.1097/00007890-199304000-00040 Baliga, 1994, CTLA4Ig prolongs allograft survival while suppressing cell-mediated immunity, Transplantation, 58, 1082, 10.1097/00007890-199411270-00005 Bai, 2002, CD2 is a dominant target for allogeneic responses, Am J Transplant, 2, 618, 10.1034/j.1600-6143.2002.20706.x Woodward, 1996, Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways, Transplantation, 62, 1011, 10.1097/00007890-199610150-00021 Sido, 1997, Modulation of the CD2 receptor and not disruption of the CD2/CD48 interaction is the principal action of CD2-mediated immunosuppression in the rat, Cell Immunol, 182, 57, 10.1006/cimm.1997.1204 Sido, 1998, Differential immunosuppressive activity of monoclonal CD2 antibodies on allograft rejection vs. specific antibody production, Eur J Immunol, 28, 1347, 10.1002/(SICI)1521-4141(199804)28:04<1347::AID-IMMU1347>3.0.CO;2-L Ono, 1969, Improved technique of heart transplantation in rats, J Thorac Cardiovasc Surg, 57, 225, 10.1016/S0022-5223(19)42744-X Driscoll, 1991, Structure of domain 1 of rat T lymphocyte CD2 antigen [see comments], Nature, 353, 762, 10.1038/353762a0 Linsley, 1991, Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation, J Exp Med, 173, 721, 10.1084/jem.173.3.721 Jaques, 1998, Thymus-dependent, anti-CD4-induced tolerance to rat cardiac allografts, Transplantation, 66, 1291, 10.1097/00007890-199811270-00005 Hunig, 1989, A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes, J Exp Med, 169, 73, 10.1084/jem.169.1.73 O'Flynn, 1985, Phytohaemagglutinin activation of T cells through the sheep red blood cell receptor, Nature, 313, 686, 10.1038/313686a0 Bohmig, 1994, Specific down regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitro, J Immunol, 152, 3720, 10.4049/jimmunol.152.8.3720 Brown, 1995, A sensitive assay for detecting low-affinity interactions at the cell surface reveals no additional ligands for the adhesion pair rat CD2 and CD48, Eur J Immunol, 25, 3222, 10.1002/eji.1830251204 Seder, 1994, CD28-mediated costimulation of interleukin 2 [IL-2] production plays a critical role in T cell priming for IL-4 and interferon gamma production, J Exp Med, 179, 299, 10.1084/jem.179.1.299 Shahinian, 1993, Differential T cell costimulatory requirements in CD28-deficient mice, Science, 261, 609, 10.1126/science.7688139 Lenschow, 1992, Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg [see comments], Science, 257, 789, 10.1126/science.1323143 Ronchese, 1994, Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivo, J Exp Med, 179, 809, 10.1084/jem.179.3.809 Schwarz, 1995, Identification of the TS2/18-recognized epitope on the CD2 molecule as a target for suppression of T cell cytokine synthesis, J Immunol, 154, 5813, 10.4049/jimmunol.154.11.5813 Boise, 1995, CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL, Immunity, 3, 87, 10.1016/1074-7613(95)90161-2 Noel, 1996, CD28 costimulation prevents cell death during primary T cell activation, J Immunol, 157, 636, 10.4049/jimmunol.157.2.636